NCT00035620View on ClinicalTrials.gov

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

PHASE2CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

January 31, 2007

Study Completion Date

April 30, 2007

Conditions

SarcomaNeutropenia

Interventions

DRUG

pegfilgrastim

pegfilgrastim

DRUG

filgrastim

filgrastim

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY